Sharps Compliance (SMED) Tops Q2 EPS by 1c

Sharps Compliance (NASDAQ: SMED) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.33 million.

For earnings history and earnings-related data on Sharps Compliance (SMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c